This article discusses recent advances in basic research that alter the view of the pathogenesis of radiation myelopathy and summarizes the available data from developmental neurobiology and preclinical studies on demyelinating diseases. These studies have produced interesting insights into oligoden
Patient compliance with drug treatment ? new perspectives on an old problem
β Scribed by Kruse, W.
- Publisher
- Springer-Verlag
- Year
- 1992
- Tongue
- English
- Weight
- 470 KB
- Volume
- 70
- Category
- Article
- ISSN
- 1432-1440
No coin nor oath required. For personal study only.
β¦ Synopsis
Compared to other variables being considered in therapeutics, patient compliance has long been given minor attention although it affects every aspect of medical care. Limited methodology of compliance measurement, in particular, has hampered major progress in research, and pre-conceptions have been reiterated. However, there is a recent surge in interest derived from new data revealed by reliable methods, i.g. continuous medication (compliance) monitoring. The visualization of dynamics in drug regimen compliance over time offers unique opportunities, both to scientific drug evaluation and therapeutics in medical practice. New perspectives related to the descriptive and explanatory side of the problem are outlined by giving examples from various therapeutic fields.
π SIMILAR VOLUMES
BACKGROUND. An Investigational New Drug (IND) treatment program allows patients access to a drug that has shown activity against a serious or life-threatening disease prior to full Food and Drug Administration (FDA) review and approval. This treatment IND program, in which patients with locally adva